Table IV.

Prognostic model for progression free survival and overall survival

Prognostic Score1	N	HR	95% CI Lower Limit	95% CI Upper Limit	p-value
0	194	1
2	103	1.30	0.97	1.76	0.08
4	14	1.41	0.76	2.62	0.28
5	38	1.66	1.13	2.46	0.01
6	12	2.21	1.19	4.11	0.01
7	35	2.34	1.58	3.47	<0.0001
9	3	1.79	0.44	7.24	0.41
11	18	5.47	3.26	9.19	<0.0001
Progression-free Survival Risk Groups
Low (Score 0)	194	1
Intermediate (Score 2,4,5)	155	1.40	1.08	1.82	0.01
High (Score 6,7,9)	50	2.28	1.61	3.22	<0.0001
Very high (Score 11)	18	5.47	3.26	9.19	<0.0001
Contrast
Intermediate vs. High		0.61	0.43	0.87	0.006
Intermediate vs. Very high		0.26	0.15	0.43	<0.0001
High vs. Very high		0.42	0.24	0.73	0.002
Overall Survival Risk Groups
Low (Score 0)	199	1
Intermediate (Score 2,4,5)	156	1.34	1.02	1.76	0.03
High (Score 6,7,9)	50	2.11	1.47	3.03	<0.0001
Very high (Score 11)	18	3.94	2.32	6.68	<0.0001
Contrast
Intermediate vs. High		0.63	0.44	0.91	0.02
Intermediate vs. Very high		0.34	0.20	0.58	<0.0001
High vs. Very high		0.54	0.30	0.96	0.03

N = number; HR = hazard ratio; CI = confidence interval; CR = complete response; PR = partial response; KPS = Karnofsky performance status; alloHCT=allogeneic haematopoietic cell transplantation; autoHCT= autologous haematopoietic cell transplantation;

¹Prognostic score determined by following:

KPS≥80 = 0 point, KPS <80 = 4 points.

Disease status CR or PR = 0 point, Chemoresistant = 5 points

Time from autoHCT to alloHCT ≥12 months = 0 point, <12 months = 2 points.